Evidence map›Paper›PMID 31818831›Full record

ArticleBMJ open2019

Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol.

Anderson Bermon, Ana Fernanda Uribe-Rodríguez, Paula Fernanda Pérez-Rivero, David Prieto-Merino, Diana Isabel Cáceres Rivera, Elizabeth Guio, Louise Atkins, Robert Horne, Elizabeth Murray, Norma Cecilia Serrano Díaz and 3 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03098186 (TXT2HEART COLOMBIA), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03098186 nacompletednot on this map

TXT2HEART COLOMBIA: Evaluation of the Efficacy and Safety of Text Messages to Improve Adherence to Cardiovascular Medications in Secondary Prevention

TypeinterventionalSponsorFundación Cardiovascular de ColombiaRan2017 to 2019Enrolled930ConditionsCardiovascular DiseaseArmsIntervention SMS, Control SMS
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Anderson BermonResearch, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia andersonbermon@fcv.org.
Ana Fernanda Uribe-RodríguezFaculty of Psychology, Universidad Pontificia Bolivariana - Seccional Bucaramanga, Floridablanca, Santander, Colombia.
Paula Fernanda Pérez-RiveroFaculty of Psychology, Universidad Pontificia Bolivariana - Seccional Bucaramanga, Floridablanca, Santander, Colombia.ORCID 0000-0001-8195-1753
David Prieto-MerinoEPH LSHTM, London School of Hygiene and Tropical Medicine, London, UK.
Diana Isabel Cáceres RiveraNursing, Universidad Cooperativa de Colombia, Bucaramanga, Santander, Colombia.
Elizabeth GuioMetabolism and Genoma Laboratory, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia.
Louise AtkinsUniversity College London Research Department of Epidemiology and Public Health, London, UK.
Robert HorneUniversity College London School of Pharmacy, London, UK.
Elizabeth MurrayUniversity College London Research Department of Primary Care and Population Health, London, UK.ORCID 0000-0002-8932-3695
Norma Cecilia Serrano DíazDirection of Research, Fundación Cardiovascular de Colombia, Bucaramanga, Santander, Colombia.
Caroline FreeEPH LSHTM, London School of Hygiene and Tropical Medicine, London, UK.
Pablo PerelEPH LSHTM, London School of Hygiene and Tropical Medicine, London, UK.
Juan P CasasResearch, Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, Massachusetts, USA.
Fundación Cardiovascular de Colombia · COLondon School of Hygiene & Tropical Medicine · GBUniversity College London · GBUniversidad Pontificia Bolivariana · COUniversidad Cooperativa de Colombia · CO

Funding

Medical Research Council MR/N021304/1
6 · The paper itself

Abstract

introductionAnti-platelet therapy, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, beta-blockers and statins are cost-effective in patients with atherosclerotic cardiovascular diseases (ASCVD) for reducing the risk of ASCVD events. Unfortunately, there is abundant evidence that adherence to these cardiovascular medications is far from ideal. A recent Cochrane review showed a potential beneficial effect of Short Message Service (SMS) interventions on adherence to medication in ASCVD patients. METHODS AND ANALYSIS: The txt2heart study is a pragmatic randomised single-blind controlled trial. The objective is to evaluate the efficacy and safety of an intervention with SMS messages delivered by mobile phones to improve adherence to cardiovascular medications in patients with ASCVD. The intervention consists of behavioural techniques delivered via SMS. The primary outcome is change in blood serum low-density lipoprotein cholesterol levels as an indicator of adherence to statins. Secondary outcomes will include systolic blood pressure as an indicator of adherence to blood-lowering therapies and heart rate as an indicator of adherence to beta-blockers, urine levels of ETHICS AND DISSEMINATION: The study will be performed in compliance with the protocol, regulatory requirements, Good Clinical Practice and ethical principles of the Declaration of Helsinki. The Ethics Committee of Fundación Cardiovascular de Colombia evaluated and approved the trial. The txt2heart Colombia trial aims to provide robust evidence to evaluate whether SMS messages delivered through mobile telephones change the behaviour of Colombian patients who have suffered a cardiovascular event. Trial results will be presented to the local health authorities, and if the intervention is effective and safe, we hope this strategy will be implemented quickly because of its low cost and wide-reaching impact on the population. TRIAL REGISTRATION NUMBER: NCT03098186.

Indexed as

Drug MonitoringReminder SystemsText MessagingCardiovascular DiseasesCell PhoneColombiaHumansPragmatic Clinical Trials as TopicSecondary PreventionSingle-Blind MethodCardiovascular diseasesHealth behaviorMedications adherencemHealthtext messaging

Identifiers

PMID31818831
PMCPMC6924706
OpenAlexW2993447381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.